Impact of yoga therapy on Pregnancy complications
Not Applicable
- Conditions
- Health Condition 1: O998- Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
- Registration Number
- CTRI/2022/07/043636
- Lead Sponsor
- SVYASA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Pregnant women with Uterine Artery Doppler (UAD) positive at 12 weeks,
Low PAPPAÂ less than 0.4 MOM
Exclusion Criteria
Pre-existing chronic hypertension
Kidney disease
Multiple pregnancies
Pregnancy with significant fetal abnormalities
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method PLGF and HRVTimepoint: At baseline ( 13th week of pregnancy) and at 32nd week of pregnancy(before DOD)
- Secondary Outcome Measures
Name Time Method 1.Depression Anxiety Assessment scale (DAAS) <br/ ><br>2.Quality of Life in Pregnancy(QOL) <br/ ><br>1.Systolic blood pressure <br/ ><br>2.diastolic blood pressure <br/ ><br> <br/ ><br>3. Pittsburgh Sleep Quality Index <br/ ><br>4.UAD(Uterine Artery Doppler) <br/ ><br>1.Weight <br/ ><br> <br/ ><br>2.BMI <br/ ><br>(Krukowski et al., 2016) <br/ ><br>1.Birth weight <br/ ><br>2.Gestational age of Delivery <br/ ><br>3.Mode of Delivery <br/ ><br>Timepoint: 13th,20th, 32nd week of Pregnancy
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways does yoga therapy modulate in placental insufficiency and preeclampsia?
How does yoga therapy compare to antihypertensive drugs in managing placental dysfunction during pregnancy?
Which biochemical markers predict response to yoga intervention in pregnancies with placental pathology?
What are the safety profiles of yoga therapy for patients with abnormal placental growth factor levels?
Are there synergistic effects of combining yoga therapy with corticosteroids for fetal lung maturity in high-risk pregnancies?